Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Third Quarter (3Q) and Nine Months (9M) ended September 30, 2020.
Context: Ambev reported results under IFRS, highlighting a "V-shaped recovery" driven by the gradual lifting of COVID-19 restrictions. The company operates in Brazil, Central America and the Caribbean (CAC), Latin America South (LAS), and Canada. Results are significantly impacted by the application of Hyperinflation Accounting (IAS 29) for Argentinean subsidiaries.
Key Financial Metrics
| Metric (R$ million) | 3Q20 | 3Q19 | 9M20 | 9M19 |
|---|---|---|---|---|
| Net Revenue | 15,604.5 | 11,957.7 | 39,822.4 | 36,742.9 |
| Normalized EBITDA | 5,073.5 | 4,410.5 | 12,654.2 | 14,222.4 |
| Normalized Profit | 2,495.9 | 2,441.8 | 5,096.3 | 7,916.4 |
| Normalized EPS (R$) | 0.15 | 0.15 | 0.31 | 0.48 |
| Cash Flow from Operations | 7,079.4 | 3,552.2 | 10,462.2 | 8,746.4 |
| CAPEX | 1,144.8 | 1,623.7 | 3,298.3 | 3,065.6 |
| Net Debt/(Cash) | (15,569.5) | (8,852.4) | (15,569.5) | (8,852.4) |
Note: Net Debt is negative, indicating a net cash position. 3Q20 Net Cash position is R$ 15.6 billion.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net revenue increased 15.1% organically in 3Q20, driven by a 12.0% volume increase. Brazil was the primary driver with 21.2% revenue growth and 19.8% volume growth. Conversely, CAC volumes declined 9.9% due to ongoing restrictions.
- Margin Compression: Gross margin decreased 440 basis points to 52.4% in 3Q20. EBITDA margin also fell 440 basis points to 32.5%. This compression was attributed to inflationary pressures in Argentina, currency headwinds, and unfavorable packaging mix (shift to aluminum cans).
- Cost Increases: Cost of Goods Sold (COGS) rose 26.6% in 3Q20. Cash COGS per hectoliter increased 16.4% due to FX impacts and inflation.
- Profitability: While 3Q20 normalized profit grew 2.2% year-over-year, the 9M20 normalized profit declined 35.6% due to the severe impact of the pandemic in the first half of the year.
- Financial Results: Net finance results deteriorated significantly to a loss of R$ 1,144.8 million in 3Q20 (vs. R$ 305.8 million loss in 3Q19), driven by losses on derivative instruments (FX hedges) and fair value adjustments.
Guidance, Outlook, and Risks
- Outlook: Management expects a continued "V-shaped recovery" as restrictions lift. However, the full impact of the pandemic remains uncertain. The company is cautious regarding Q4 2020 in Canada due to rising cases and potential new shutdowns.
- Strategic Focus: Emphasis on innovation (new flavors, wellness products), digital platforms (direct-to-consumer), and premiumization. The company is leveraging its strong cash position to support commercial strategy.
- Risks and Contingencies:
- Hyperinflation in Argentina: Significant volatility in results due to IAS 29 application, impacting revenue and EBITDA recognition.
- Currency Fluctuations: Exposure to Argentine Peso and Brazilian Real depreciation affecting financial results and COGS.
- COVID-19: Ongoing restrictions in specific markets (Bolivia, Dominican Republic, Panama) and potential resurgence in Canada.
- Exceptional Items: R$ 159.8 million in exceptional expenses in 3Q20 related to COVID-19 safety measures and restructuring.
Investor Verification Checklist
- Argentina Hyperinflation Impact: Verify the specific impact of IAS 29 on the reported revenue and EBITDA figures for the LAS segment, as this significantly distorts organic growth comparisons.
- FX Hedging Costs: Review the R$ 562.7 million loss on derivative instruments to understand the sustainability of these costs given the high inflation environment in Argentina.
- Volume Recovery Sustainability: Assess whether the 12% volume growth in 3Q20 is sustainable or if it is a temporary rebound from low 2Q20 baselines, particularly in markets with lingering restrictions.
- Net Cash Position: Confirm the R$ 15.6 billion net cash position and its utilization strategy, given the reduction in CAPEX (-29.5% in 3Q20).
- Margin Trajectory: Monitor the trend of gross and EBITDA margins to determine if cost inflation and mix shifts are stabilizing or continuing to compress profitability.